The design bureau of the Enterprise on the basis of the Instrumentation and Automation Department,, under the guidance of A.S. Mishkin, developed unique designer equipment.
The development of the Enterprise focused on the launch of new products is possible provided that an integrated approach to solution of the problems of development of new technologies that should successfully pass scaling in industrial production is organized.
A wide range of drugs, as well as numerous stages and production cycles, require certain types of equipment.
The Enterprise not only creates pharmaceutical products, but also designs R&D equipment at a high level, which allows producing of experimental series of products and development of technologies in the laboratory conditions, as well as automation of technological operations in production, increasing their productivity.
The most stringent requirements are applied to pharmaceutical equipment providing that the pharmaceutical manufacturing process meets quality standards.
The design bureau of the Enterprise on the basis of the Instrumentation and Automation Department, under the guidance of A.S. Mishkin, developed unique designer equipment that not only proved its reliability and compliance with all the requirements, but also made it possible to make the process more flexible, efficient and safe.
The original technical solution was used in a device for filling and sealing of a syringe with a liquid drug (RF patent No. 151283) and an automatic assembly for filling of syringes with a liquid drug and their sealing with piston cuffs (RF patent No. 155666). It allows to use the vacuum principle of sealing in conditions of laboratory and small-scale industrial production. This development in 2016 was awarded with a gold medal at the XII Moscow International Innovation Forum "Accurate measurements are the basics of quality and safety". The equipment is used in the production of small series of single prefilled glass syringes with the capacity of 1 ml, for example, in the development of new drugs that are included in international standards of pain control in accordance with the recommendations of the World Health Organization for the provision of palliative care for cancer patients.
Another device is designed for automatic filling and sealing of 2 ml ampoules in laboratory conditions. Previously, this operation had to be done manually. Currently, the unit allows to fill and seal 500 ampoules per hour. Moreover, the uniqueness of this development lies not only in the automation of the process, but also in the exclusion of the use of air and pure oxygen in the sealing process, which allows to protect completely the process operator.
The devices for filling and sealing of ampoules in laboratory conditions developed at the Enterprise, due to the indicated design features, are extremely interesting not only in terms of their technical characteristics, but also stand out in comparison with the price of similar imported ones.
A tablet regeneration unit intended for check and rejection of blister products, and a device for assembling of a blister pack into a box (RF patent No. 139715), used for intermediate assembly of a blister pack into a box when packing multi-component products (vial, dropper, insert, etc.), allowed to increase the productivity of the process by 5 times with minimal investment.
The developments of the Enterprise are not limited to the tasks of its own laboratories and production workshops. The FSUE Moscow Endocrine Plant actively cooperates with a wide range of organizations, offering them highly specialized, effective technical solutions.
So, the Enterprise developed a device for trimming, filling and packaging of syringes containing implantable solid objects (RF patent No. 138758) for the manufacture of medical devices necessary for the administration of solid implantable objects (tablets, stimulants, etc.) during surgical operations.
The FSUE Moscow Endocrine Plant has the potential for small-scale production of equipment under development, adapting it to the requirements of internal and external customers, which are considered by numerous partners.
Comment type is not specified in the component properties.